<DOC>
	<DOCNO>NCT00420173</DOCNO>
	<brief_summary>Cutaneous lupus erythematosus ( CLE ) disease wide spectrum clinical manifestation variable prognosis . The aim study create standardize evaluation different subtypes disease order receive overview spectrum clinical laboratory feature well therapeutic strategy patient CLE .</brief_summary>
	<brief_title>Interdisciplinary Study Group Lupus Erythematosus ( ISGLE )</brief_title>
	<detailed_description>Methods : A core set questionnaire develop course `` European Society Cutaneous Lupus Erythematosus ( EUSCLE ) '' , total 40 patient ( 32 female , 8 male ) two centre , Germany Sweden , include study . Results : CLE diagnose 39 individual ( 5 acute CLE , 10 subacute CLE , 13 chronic CLE , 18 intermittent CLE ) one individual present systemic manifestation disease . Furthermore , disease onset duration well activity damage skin lesion use modified CLASI examine . Interestingly , 75 % patient CLE show positive history photosensitivity , 62.5 % exhibit characteristic lesion standardize phototesting . Laboratory analysis reveal positive antinuclear antibody 50 % patient , positive anti-Ro/SSA 12 positive anti-La/SSB antibody 8 case . The predominantly use treatment include sunscreen ( 38 patient ) , topical steroid ( 31 patient ) , topical calcineurin inhibitor ( 12 patient ) , chloroquine ( 19 patient ) , hydroxychloroquine ( 11 patient ) , systemic steroid ( 12 patient ) . Conclusions : The new core set questionnaire enable clinician characterize different skin manifestation involve CLE evaluate disease activity reasonable treatment modality . Furthermore , epidemiological data laboratory feature assess various subtypes . In future , standardized evaluation might lead development diagnostic guideline evidence base therapeutic strategy thus improve quality care patient CLE .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Lupus Erythematosus , Cutaneous</mesh_term>
	<criteria>cutaneous lupus erythematosus confirm histological analysis photoprovocationtest perform advance write informed consent available prior procedure patient condition contrary mention criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>cutaneous lupus erythematosus</keyword>
	<keyword>standardize evaluation</keyword>
	<keyword>core set questionnaire</keyword>
	<keyword>epidemiological data</keyword>
	<keyword>laboratory feature</keyword>
</DOC>